Tags

Type your tag names separated by a space and hit enter

[Subcutaneous continuous apomorphine infusion: treatment initiation and follow up].
Rev Neurol. 2012; 55 Suppl 1:S21-4.RN

Abstract

Continuous apomorphine infusion has been an established treatment for advanced Parkinson's disease for over two decades. This article reviews the different methods for starting treatment and propose a consensus methodology for it, as well as for the modification of prior treatment, in order to standardize and reduce the variability of clinical practice.

Authors+Show Affiliations

Hospital General Universitario Gregorio Maranon, 28007 Madrid, Espana.No affiliation info available

Pub Type(s)

English Abstract
Journal Article
Review

Language

spa

PubMed ID

23169229

Citation

Grandas, Francisco J., and Ángel Sesar-Ignacio. "[Subcutaneous Continuous Apomorphine Infusion: Treatment Initiation and Follow Up]." Revista De Neurologia, vol. 55 Suppl 1, 2012, pp. S21-4.
Grandas FJ, Sesar-Ignacio Á. [Subcutaneous continuous apomorphine infusion: treatment initiation and follow up]. Rev Neurol. 2012;55 Suppl 1:S21-4.
Grandas, F. J., & Sesar-Ignacio, Á. (2012). [Subcutaneous continuous apomorphine infusion: treatment initiation and follow up]. Revista De Neurologia, 55 Suppl 1, S21-4.
Grandas FJ, Sesar-Ignacio Á. [Subcutaneous Continuous Apomorphine Infusion: Treatment Initiation and Follow Up]. Rev Neurol. 2012;55 Suppl 1:S21-4. PubMed PMID: 23169229.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Subcutaneous continuous apomorphine infusion: treatment initiation and follow up]. AU - Grandas,Francisco J, AU - Sesar-Ignacio,Ángel, PY - 2012/11/22/entrez PY - 2012/10/20/pubmed PY - 2014/8/19/medline SP - S21 EP - 4 JF - Revista de neurologia JO - Rev Neurol VL - 55 Suppl 1 N2 - Continuous apomorphine infusion has been an established treatment for advanced Parkinson's disease for over two decades. This article reviews the different methods for starting treatment and propose a consensus methodology for it, as well as for the modification of prior treatment, in order to standardize and reduce the variability of clinical practice. SN - 1576-6578 UR - https://www.unboundmedicine.com/medline/citation/23169229/[Subcutaneous_continuous_apomorphine_infusion:_treatment_initiation_and_follow_up]_ L2 - https://medlineplus.gov/parkinsonsdisease.html DB - PRIME DP - Unbound Medicine ER -